The researchers used transmembrane region structure of platelet-derived growth factor receptors and SIRPα avariant co-modified exosomes (SIRPα-exosomes), which can destroy the interaction of CD47-SIRPαleads to increase the number of cells phagocytized by macrophages, thereby inhibiting tumor growth. This evidence concerns the gene SIRPA and neoplasm.